ClinicalTrials.gov
ClinicalTrials.gov Menu

A French Multi-centric Atrial Fibrillation Catheter Ablation Survey (FrenchAF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01918670
Recruitment Status : Unknown
Verified August 2013 by Serge Boveda, Clinique Pasteur.
Recruitment status was:  Active, not recruiting
First Posted : August 8, 2013
Last Update Posted : August 8, 2013
Sponsor:
Collaborators:
University Hospital, Grenoble
Nouvelle Clinique Nantaise, Nantes, France
Hôpital Privé de Parly II - Le Chesnay
Rennes University Hospital
University Hospital of Rouen, Rouen, France
Information provided by (Responsible Party):
Serge Boveda, Clinique Pasteur

Brief Summary:

Atrial fibrillation is the most frequent sustained arrhythmia. Catheter ablation is a procedure that is currently used for the treatment of symptomatic atrial fibrillation patients.

We have organized a multi-centric national survey of catheter ablation of atrial fibrillation in order to have a feedback on the type of procedures being performed and the overall results (freedom of atrial fibrillation) over an average follow-up of 18 months.


Condition or disease Intervention/treatment
Observation of Outcome After Catheter Ablation of Atrial Fibrillation Procedure: catheter ablation of atrial fibrillation

Study Type : Observational [Patient Registry]
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 18 Months
Official Title: A French Multi-centric Atrial Fibrillation Catheter Ablation Survey
Study Start Date : November 2010
Actual Primary Completion Date : July 2013
Estimated Study Completion Date : December 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort Intervention/treatment
Pasteur Procedure: catheter ablation of atrial fibrillation
electric pulmonary vein disconnection
Grenoble Procedure: catheter ablation of atrial fibrillation
electric pulmonary vein disconnection
Nantes Procedure: catheter ablation of atrial fibrillation
electric pulmonary vein disconnection
Parly Procedure: catheter ablation of atrial fibrillation
electric pulmonary vein disconnection
Rennes Procedure: catheter ablation of atrial fibrillation
electric pulmonary vein disconnection
Rouen Procedure: catheter ablation of atrial fibrillation
electric pulmonary vein disconnection



Primary Outcome Measures :
  1. Atrial fibrillation relapse [ Time Frame: starting 3 months after the procedure till an average of 18months follow-up ]
    Documentation of atrial fibrillation relapse (symptomatic or asymptomatic) after the first 3 months after the index procedure


Secondary Outcome Measures :
  1. Early atrial fibrillation relapse [ Time Frame: first 3 months ]
    Documented atrial fibrillation relapse (symptomatic or asymptomatic) in the first 3 months after the index procedure



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients undergoing catheter ablation in one of the registry centers
Criteria

Inclusion Criteria:

  • all patients undergoing catheter ablation of atrial fibrillation or left atrial flutter

Exclusion Criteria:

  • patients undergoing catheter ablation of other types of arrhythmia

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01918670


Locations
France
Clinique Pasteur
Toulouse, France
Sponsors and Collaborators
Clinique Pasteur
University Hospital, Grenoble
Nouvelle Clinique Nantaise, Nantes, France
Hôpital Privé de Parly II - Le Chesnay
Rennes University Hospital
University Hospital of Rouen, Rouen, France

Responsible Party: Serge Boveda, MD, Clinique Pasteur
ClinicalTrials.gov Identifier: NCT01918670     History of Changes
Other Study ID Numbers: FrenchAFAblationSurvey
First Posted: August 8, 2013    Key Record Dates
Last Update Posted: August 8, 2013
Last Verified: August 2013

Keywords provided by Serge Boveda, Clinique Pasteur:
atrial fibrillation; catheter ablation; relapse; stroke; death

Additional relevant MeSH terms:
Atrial Fibrillation
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes